{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:08:23Z","timestamp":1760267303294,"version":"3.40.5"},"reference-count":99,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["transplantationreviews.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.trre.2014.06.001","type":"journal-article","created":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T07:46:42Z","timestamp":1406015202000},"page":"16-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The clinical relevance of alloantibody in liver transplantation"],"prefix":"10.1016","volume":"29","author":[{"given":"C.K.","family":"Burghuber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.K.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5960-6806","authenticated-orcid":false,"given":"S.J.","family":"Knechtle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2014.06.001_bb0005","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(66)92829-7","article-title":"Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells","volume":"2","author":"Kissmeyer-Nielsen","year":"1966","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2014.06.001_bb0010","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/204998b0","article-title":"Microdroplet Assay Of Human Serum Cytotoxins","volume":"204","author":"Terasaki","year":"1964","journal-title":"Nature"},{"key":"10.1016\/j.trre.2014.06.001_bb0015","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/00007890-196707001-00041","article-title":"Serotyping for homotransplantation. X. Survival of 196 grafted kidneys subsequent to typing","volume":"5","author":"Terasaki","year":"1967","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.06.001_bb0020","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2014.06.001_bb0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00007890-198701000-00003","article-title":"Hepatic transplantation into sensitized recipients. Demonstration of hyperacute rejection","volume":"43","author":"Knechtle","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.06.001_bb0030","first-page":"1082","article-title":"Signs of hyperacute rejection of liver grafts in rhesus monkeys after donor-specific presensitization","volume":"19","author":"Gubernatis","year":"1987","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2014.06.001_bb0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0140-6736(72)90288-7","article-title":"Immunopathological studies of orthotopic human liver allografts","volume":"1","author":"Andres","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2014.06.001_bb0040","first-page":"489","article-title":"Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers","volume":"132","author":"Demetris","year":"1988","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trre.2014.06.001_bb0045","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.1840160310","article-title":"A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies","volume":"16","author":"Demetris","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.trre.2014.06.001_bb0050","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1111\/j.1600-6143.2006.01554.x","article-title":"Isolated donor specific alloantibody-mediated rejection after ABO compatible liver transplantation","volume":"6","author":"Watson","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2014.06.001_bb0055","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1097\/TP.0b013e318208138c","article-title":"Clinical perspective of acute humoral rejection after blood type-compatible liver transplantation","volume":"91","author":"Chan","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.06.001_bb0060","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00007890-199008000-00027","article-title":"Specific absorption of lymphocytotoxic alloantibodies by the liver in inbred rats","volume":"50","author":"Gugenheim","year":"1990","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.06.001_bb0065","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/00007890-198903000-00025","article-title":"Soluble HLA antigens in the circulation of liver graft recipients","volume":"47","author":"Davies","year":"1989","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.06.001_bb0070","first-page":"2857","article-title":"Release of soluble MHC class I antigens before and after orthotopic liver retransplantation in the rat","volume":"25","author":"Kamada","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2014.06.001_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2009.08.008","article-title":"Immune tolerance: what is unique about the liver","volume":"34","author":"Tiegs","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.trre.2014.06.001_bb0080","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1006\/jsre.1999.5734","article-title":"Increased risk of antibody-mediated rejection of reduced-size liver allografts","volume":"87","author":"Astarcioglu","year":"1999","journal-title":"J Surg Res"},{"key":"10.1016\/j.trre.2014.06.001_bb0085","first-page":"1383","article-title":"Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model","volume":"142","author":"Nakamura","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trre.2014.06.001_bb0090","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/00007890-199005000-00004","article-title":"Hyperacute rejection in porcine liver transplantation. I. Clinical characteristics, histopathology, and disappearance of donor-specific lymphocytotoxic antibody from serum","volume":"49","author":"Merion","year":"1990","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.06.001_bb0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1399-0012.1989.tb00531.x","article-title":"Evidence for hyperacute rejection of human liver grafts: the case of the canary kidneys","volume":"3","author":"Starzl","year":"1989","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2014.06.001_bb0100","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/00007890-199304000-00025","article-title":"Probable antibody-mediated failure of two sequential ABO-compatible hepatic allografts in a single recipient","volume":"55","author":"Ratner","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.06.001_bb0105","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/B978-0-12-385493-3.00012-7","article-title":"Clinical cytometry and progress in HLA antibody detection","volume":"103","author":"Bray","year":"2011","journal-title":"Methods Cell Biol"},{"key":"10.1016\/j.trre.2014.06.001_bb0110","first-page":"334","article-title":"HLA compatibility and organ transplant survival. Collaborative Transplant Study","volume":"1","author":"Opelz","year":"1999","journal-title":"Rev Immunogenet"},{"key":"10.1016\/j.trre.2014.06.001_bb0115","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/lt.20680","article-title":"The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: an analysis of the OPTN database","volume":"12","author":"Navarro","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2014.06.001_bb0120","first-page":"705","article-title":"The antibody crossmatch in liver transplantation","volume":"100","author":"Gordon","year":"1986","journal-title":"Surgery"},{"key":"10.1016\/j.trre.2014.06.001_bb0125","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1525-1594.1996.tb00642.x","article-title":"UCLA liver transplantation: analysis of immunological factors affecting outcome","volume":"20","author":"Dawson","year":"1996","journal-title":"Artif Organs"},{"key":"10.1016\/j.trre.2014.06.001_bb0130","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/00007890-199511000-00024","article-title":"IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry","volume":"60","author":"Donaldson","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.06.001_bb0135","first-page":"129","article-title":"Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction","volume":"6","author":"Starzl","year":"1974","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2014.06.001_bb0140","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0016-5085(79)90294-4","article-title":"Fifteen years of clinical liver transplantation","volume":"77","author":"Starzl","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trre.2014.06.001_bb0145","first-page":"286","article-title":"Successful liver transplantation from crossmatch-positive donors","volume":"13","author":"Iwatsuki","year":"1981","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2014.06.001_bb0150","first-page":"396","article-title":"Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy","volume":"23","author":"Takaya","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2014.06.001_bb0155","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/00007890-199202010-00026","article-title":"The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors","volume":"53","author":"Takaya","year":"1992","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.06.001_bb0160","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00000658-199608000-00009","article-title":"Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch","volume":"224","author":"Doyle","year":"1996","journal-title":"Ann Surg"},{"key":"10.1016\/j.trre.2014.06.001_bb0165","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00007890-199707150-00011","article-title":"A positive crossmatch in liver transplantation\u2013no effect or inappropriate analysis? A prospective study","volume":"64","author":"Hathaway","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.06.001_bb0170","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2214\/ajr.147.4.657","article-title":"Vascular complications after liver transplantation: a 5-year experience","volume":"147","author":"Wozney","year":"1986","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.trre.2014.06.001_bb0175","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1600-6143.2008.02541.x","article-title":"Early hepatic artery thrombosis after liver transplantation: a systematic review of the incidence, outcome and risk factors","volume":"9","author":"Bekker","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2014.06.001_bb0180","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1097\/00007890-200104270-00025","article-title":"Significance of a T-lymphocytotoxic crossmatch in liver and combined liver-kidney transplantation","volume":"71","author":"Neumann","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.06.001_bb0185","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/lt.22474","article-title":"Implications of a positive crossmatch in liver transplantation: a 20-year review","volume":"18","author":"Ruiz","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2014.06.001_bb0190","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.humimm.2009.04.009","article-title":"Analysis of positive kidney, heart, and liver transplant crossmatches reported to the Collaborative Transplant Study","volume":"70","author":"Opelz","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1016\/j.trre.2014.06.001_bb0195","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.sla.0000108681.24374.02","article-title":"Impact of surgical and immunological parameters in pediatric liver transplantation: a multivariate analysis in 500 consecutive recipients of primary grafts","volume":"239","author":"Evrard","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.trre.2014.06.001_bb0200","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1399-0012.1994.tb00956.x","article-title":"High one-month liver graft failure rates in flow cytometry crossmatch-positive recipients","volume":"8","author":"Ogura","year":"1994","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2014.06.001_bb0205","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/00007890-199503150-00017","article-title":"The flow cytometric crossmatch in liver transplantation","volume":"59","author":"Talbot","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.06.001_bb0210","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1097\/00007890-200004150-00047","article-title":"A large, single center investigation of the immunogenetic factors affecting liver transplantation","volume":"69","author":"Doran","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.06.001_bb0215","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1034\/j.1600-6143.2001.10209.x","article-title":"Susceptibility of liver allografts to high or low concentrations of preformed antibodies as measured by flow cytometry","volume":"1","author":"Scornik","year":"2001","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2014.06.001_bb0220","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/lt.21408","article-title":"Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility","volume":"14","author":"Castillo-Rama","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2014.06.001_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/lt.23694","article-title":"Liver transplantation with strongly positive crossmatch: case study and literature review","author":"Leonard","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2014.06.001_bb0230","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/j.1600-6143.2012.03995.x","article-title":"Prevalence, course and impact of HLA donor-specific antibodies in liver transplantation in the first year","volume":"12","author":"Taner","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2014.06.001_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/lt.23707","article-title":"Pretransplant donor-specific anti-hla antibodies as predictors of early allograft rejection in ABO-compatible liver transplantation","author":"Musat","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2014.06.001_bb0240","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/lt.23687","article-title":"Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation","volume":"19","author":"O'Leary","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2014.06.001_bb0245","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/lt.23788","article-title":"Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss","volume":"20","author":"O'Leary","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2014.06.001_bb0250","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/lt.21981","article-title":"Human leukocyte antigen crossmatch testing is important for liver retransplantation","volume":"16","author":"Goh","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2014.06.001_bb0255","first-page":"2510","article-title":"Posttransplant donor-specific T-lymphocytotoxic antibody in liver transplant patients with a positive crossmatch","volume":"24","author":"Kobayashi","year":"1992","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2014.06.001_bb0260","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/hep.1840210519","article-title":"Immunoglobulin G lymphocytotoxic antibodies in clinical liver transplantation: studies toward further defining their significance","volume":"21","author":"Ma\u00f1ez","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.trre.2014.06.001_bb0265","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/00007890-199902270-00014","article-title":"Postoperative flow cytometry crossmatch in living donor liver transplantation: clinical significance of humoral immunity in acute rejection","volume":"67","author":"Kasahara","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.06.001_bb0270","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/lt.22233","article-title":"Liver allograft antibody-mediated rejection with demonstration of sinusoidal C4d staining and circulating donor-specific antibodies","volume":"17","author":"Kozlowski","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2014.06.001_bb0275","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/j.1600-6143.2011.03593.x","article-title":"High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant","volume":"11","author":"O'Leary","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2014.06.001_bb0280","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/lt.23451","article-title":"Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with chronic rejection and graft loss after liver transplantation","volume":"18","author":"Kaneku","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2014.06.001_bb0285","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/lt.20154","article-title":"Immunoglobulin-G subclass antidonor reactivity in transplant recipients","volume":"10","author":"Gao","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2014.06.001_bb0290","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/ajt.12212","article-title":"De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients","volume":"13","author":"Kaneku","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2014.06.001_bb0295","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/ajt.12651","article-title":"Prevalence, incidence and risk factors for donor-specific anti-hla antibodies in maintenance liver transplant patients","volume":"14","author":"Del Bello","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2014.06.001_bb0300","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00007890-198802000-00030","article-title":"Analysis of sequential changes in major histocompatibility complex expression in human liver grafts after transplantation","volume":"45","author":"Steinhoff","year":"1988","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.06.001_bb0305","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.humimm.2005.01.032","article-title":"Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin","volume":"66","author":"Zachary","year":"2005","journal-title":"Hum Immunol"},{"key":"10.1016\/j.trre.2014.06.001_bb0310","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/00007890-199403270-00025","article-title":"Donor species complement after liver xenotransplantation. The mechanism of protection from hyperacute rejection","volume":"57","author":"Valdivia","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.06.001_bb0315","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1084\/jem.191.12.2183","article-title":"Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in Caucasians. The load of RCCX genetic diversity on major histocompatibility complex-associated disease","volume":"191","author":"Blanchong","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.trre.2014.06.001_bb0320","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1681\/ASN.2010050513","article-title":"Genotypic diversity of complement component C4 does not predict kidney transplant outcome","volume":"22","author":"Wahrmann","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2014.06.001_bb0325","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00007890-198508000-00009","article-title":"Fourth component of complement (C4) polymorphism in human orthotopic liver transplantation","volume":"40","author":"W\u00f6lpl","year":"1985","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.06.001_bb0330","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0171-2985(80)80043-X","article-title":"Change in serum properdin factor B phenotype following human orthoptic liver transplantation","volume":"158","author":"Hauptmann","year":"1980","journal-title":"Immunobiology"},{"key":"10.1016\/j.trre.2014.06.001_bb0335","first-page":"88","article-title":"Combined liver-kidney transplantation: analysis of patients with preformed lymphocytotoxic antibodies","volume":"20","author":"Fung","year":"1988","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2014.06.001_bb0340","first-page":"331","article-title":"Evidence that the liver does not always protect the kidney from hyperacute rejection in combined liver-kidney transplantation across a positive lymphocyte crossmatch","volume":"50","author":"Eid","year":"1990","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.06.001_bb0345","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0966-3274(94)90080-9","article-title":"Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies","volume":"2","author":"Saidman","year":"1994","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.trre.2014.06.001_bb0350","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1097\/TP.0b013e3182184181","article-title":"Combined liver-kidney transplants: allosensitization and recipient outcomes","volume":"91","author":"Askar","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.06.001_bb0355","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1600-6143.2011.03467.x","article-title":"Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver\/kidney transplants","volume":"11","author":"Dar","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2014.06.001_bb0360","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/ajt.12147","article-title":"Class II alloantibody and mortality in simultaneous liver-kidney transplantation","volume":"13","author":"O'Leary","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2014.06.001_bb0365","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/lt.22302","article-title":"Complement component 4d immunostaining in liver allografts of patients with de novo immune hepatitis","volume":"17","author":"Aguilera","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2014.06.001_bb0370","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1053\/jlts.2003.50236","article-title":"Are preformed antibodies to biliary epithelial cells of clinical importance in liver transplantation?","volume":"9","author":"Ge","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2014.06.001_bb0375","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/lt.21620","article-title":"Evidence for no relevance of anti-major histocompatibility complex class I-related chain a antibodies in liver transplantation","volume":"14","author":"Uzunel","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2014.06.001_bb0380","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/j.1432-2277.2005.00200.x","article-title":"A case of acute humoral rejection in liver transplantation: successful treatment with plasmapheresis and mycophenolate mofetil","volume":"18","author":"Rostron","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2014.06.001_bb0385","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/lt.23403","article-title":"Sinusoidal C4d deposits in liver allografts indicate an antibody-mediated response: diagnostic considerations in the evaluation of liver allografts","volume":"18","author":"Kozlowski","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2014.06.001_bb0390","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1399-0012.2004.00310.x","article-title":"Lobular damage caused by cellular and humoral immunity in liver allograft rejection","volume":"19","author":"Sawada","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2014.06.001_bb0395","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2559.2007.02677.x","article-title":"C4d immunopositivity is uncommon in ABO-compatible liver allografts, but correlates partially with lymphocytotoxic antibody status","volume":"50","author":"Bellamy","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.trre.2014.06.001_bb0400","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1600-6143.2010.03414.x","article-title":"The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation","volume":"11","author":"Musat","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2014.06.001_bb0405","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/ndt\/gfl594","article-title":"C4d staining of renal allograft biopsies: a comparative analysis of different staining techniques","volume":"22","author":"Seemayer","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2014.06.001_bb0410","first-page":"784","article-title":"Re-examination of sinusoidal deposition of complement 4d in liver allografts: experience from a single institution","volume":"7","author":"Dugum","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.trre.2014.06.001_bb0415","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/lt.23789","article-title":"Application of complement component 4d immunohistochemistry to ABO-compatible and ABO-incompatible liver transplantation","volume":"20","author":"Salah","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2014.06.001_bb0420","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00007890-199307000-00012","article-title":"Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejection","volume":"56","author":"Matsumoto","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2014.06.001_bb0425","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/S0041-1345(99)00256-0","article-title":"Increased bile duct complications and\/or chronic rejection in crossmatch positive human liver allografts","volume":"31","author":"Takaya","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2014.06.001_bb0430","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1478-3231.2012.02810.x","article-title":"Genetic, immunological and clinical risk factors for biliary strictures following liver transplantation","volume":"32","author":"Iacob","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.trre.2014.06.001_bb0435","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1432-2277.2009.01022.x","article-title":"Prevalence of anti-HLA antibodies after liver transplantation","volume":"23","author":"Fontana","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2014.06.001_bb0440","article-title":"Impact of post-transplant flow cytometric panel-reactive antibodies on late-onset hepatic venous outflow obstruction following pediatric living donor liver transplantation","author":"Urahashi","year":"2013","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2014.06.001_bb0445","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/lt.23534","article-title":"Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts","volume":"18","author":"Miyagawa-Hayashino","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2014.06.001_bb0450","doi-asserted-by":"crossref","DOI":"10.1002\/lt.23854","article-title":"Donor-specific alloantibodies are associated with fibrosis progression after liver-transplantation in HCV-infected patients","author":"O'Leary","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2014.06.001_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2014.02.010","article-title":"Antibody-mediated rejection in ABO compatible husband to wife living donor liver transplant and review of the literature","author":"Kheradmand","year":"2014","journal-title":"Hum Immunol"},{"key":"10.1016\/j.trre.2014.06.001_bb0460","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1111\/j.1600-6143.2009.02714.x","article-title":"Acute humoral rejection in an ABO compatible combined liver-kidney transplant\u2013the kidney is not always protected","volume":"9","author":"Reichman","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2014.06.001_bb0465","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1111\/j.1600-6143.2012.04126.x","article-title":"Bortezomib for acute antibody-mediated rejection in liver transplantation","volume":"12","author":"Paterno","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2014.06.001_bb0470","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1111\/tri.12120","article-title":"Four-year allograft survival in a highly sensitized combined liver-kidney transplant patient despite unsuccessful anti-HLA antibody reduction with rituximab, splenectomy, and bortezomib","volume":"26","author":"Koch","year":"2013","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2014.06.001_bb0475","doi-asserted-by":"crossref","DOI":"10.1111\/tri.12330","article-title":"Conversion to mammalian target of rapamycin inhibitors increases risk of de novo donor-specific antibodies","author":"Croze","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2014.06.001_bb0480","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ajt.12526","article-title":"Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection","volume":"14","author":"Kim","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2014.06.001_bb0485","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2014.06.001_bb0490","first-page":"247","article-title":"Targeting complement at the time of transplantation","volume":"vol. 734","author":"Sacks","year":"2012"},{"key":"10.1016\/j.trre.2014.06.001_bb0495","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/jama.2011.2014","article-title":"Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants","volume":"307","author":"Feng","year":"2012","journal-title":"JAMA"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X14000548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X14000548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T22:07:22Z","timestamp":1746310042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X14000548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0955470X14000548"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2014.06.001","relation":{},"ISSN":["0955-470X"],"issn-type":[{"type":"print","value":"0955-470X"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical relevance of alloantibody in liver transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2014.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}